Biopredia Biological Technology Co., Ltd established on December 26, 2014, is registered in Taizhou pharmaceutical high tech Industrial Development Zone (also known as "China Pharmaceutical city") phase IV, with its R & D Center——Nanjing BioPredia Medicine Co.,Ltd (a wholly-owned subsidiary) and located in Nanjing High-tech Development Zone. The company is founded by a team of experts who have been engaged in in vitro diagnosis technology, product development and quality management for a long time at home and abroad. Adhering to the business philosophy of "quality first, customer first, innovative development, and endless refinement", the company is committed to the research of early accurate diagnosis of complex diseases, especially the development of liquid chip technology (flow fluorescence technology) and immune multi factor joint detection products to let more people enjoy the benefits of international advanced diagnostic technology. Liquid chip technology has the advantages of high accuracy and detection efficiency, good repeatability, less sample use and low cost. This technology has been listed as the frontier technology and product of the 13th five year national science and technology innovation plan and the 13th five year plan for scientific and technological innovation of medical devices. The company has developed an automated multiplex flow fluorescence detection system, and has successfully developed a series of products such as endocrine hormones, tumor markers, tumor immunotherapy monitoring, cytokines and so on. The company R & D laboratory, equipment production and in vitro diagnostic reagent purification production workshop, production and operation qualification is also complete.
　　The company has completed a round of fund and related industry capital investment, established a certain marketing network, and started to establish long-term business relationship with some general hospitals, and its products and services have been highly praised.
　　A small step leads to a thousand miles. The company will enhance its capability in an all-round way, provide close support for clinical users with high-quality products and perfect services, and take every solid step on the road of development.